• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.78% Nasdaq Up0.70%

    Albany Molecular Research Inc. (AMRI)

    -NMS
    19.97 0.00(0.00%) 11:05AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Net Income (2,223) (1,861) (8,641) 3,724  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation7,266  7,033  6,741  6,425  
    Adjustments To Net Income3,404  5,287  1,908  1,458  
    Changes In Accounts Receivables(532)(15,792)10,068  2,532  
    Changes In Liabilities1,620  (5,045)(4,416)5,158  
    Changes In Inventories(3,380)6,140  (5,284)(5,535)
    Changes In Other Operating Activities(1,784)2,229  (827)(1,324)
    Total Cash Flow From Operating Activities 4,371   (2,009) (451) 12,438  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(4,127)(5,176)(5,567)(3,494)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities(59,340)(55)(107,113)(38,800)
    Total Cash Flows From Investing Activities (63,467) (5,231) (112,680) (42,294)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock561  140  497  67  
    Net Borrowings39,343  36,395  945  (6,930)
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 41,080   36,409   1,808   (6,486)
    Effect Of Exchange Rate Changes(464)(590)(678)136  
    Change In Cash and Cash Equivalents (18,480) 28,579   (112,001) (36,206)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.